Oral Session 3-9A MM: Biology

[OS3-9A-3] MYC involves myeloma progression by abolishing tumor suppressive function of p53-miRNA 34 axis

Yuki Murakami¹, Kei Masuda¹, Tsukasa Oda², Yuta Masuda¹, Hikaru Hattori¹, Rei Ishihara¹, Kazuki Honma¹, Saki Watanabe¹, Yuko Kuroda¹, Nobuhiko Kobayashi³, Takayuki Saitoh¹, Hirono Iriuchishima⁵, Hiromi Koiso³, Takuma Ishizaki³, Hiroaki Shimizu³, Yohei Osaki⁴, Akihiko Yokohama⁵, Norifumi Tsukamoto⁴, Nanami Gotoh¹, Tetsuhiro Kasamatsu¹, Hirokazu Murakami¹, Hiroshi Handa³ (1.Graduate School of Health Sciences, Gunma University, Gunma, Japan, 2.Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan, 3.Department of Hematology, Gunma University, Gunma, Japan, 4.Oncology Center, Gunma University Hospital, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan)